APPLICATION
ANDA201044
TYPE
ANDA
ORIGINAL APPROVAL
2017-02-07
LATEST ACTION
2018-03-07
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
ETOMIDATEPrescription
ETOMIDATE 2MG/ML · INJECTABLE · INJECTION
Approval history
2018-03-07Labeling · Supplement 1 · standardAP
2017-02-07Not Applicable · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.